Quantcast
Last updated on April 24, 2014 at 1:21 EDT

Latest Staphylococcaceae Stories

2012-08-07 02:28:46

AUSTIN, Texas and TORONTO, Aug. 7, 2012 /PRNewswire/ - Affinium Pharmaceuticals announced today that full recruitment has been achieved in its multi-center Phase 2 clinical trial evaluating oral AFN-1252 in acute bacterial skin & skin structure infections ("ABSSSI"). This Phase 2 trial is the first human efficacy study conducted with a new class of antibiotics designed to specifically inhibit staphylococcal fatty acid biosynthesis via a new drug target, the fatty acid synthase II...

2012-07-27 12:35:08

Infections caused by methicillin-resistant Staphylococcus aureus (MRSA) doubled at academic medical centers in the U.S. between 2003 and 2008, according to a report published in the August issue of Infection Control and Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America. Researchers from the University of Chicago Medicine and the University HealthSystem Consortium (UHC) estimate hospitalizations increased from about 21 out of every 1,000 patients...

2012-07-24 02:28:51

CHICAGO, July 24, 2012 /PRNewswire-USNewswire/ -- Join us in the fight against MRSA at the Fourth Annual World MRSA Day Kickoff event and Global MRSA Summit on September 29, 2012 in Chicago. The annual event is organized by MRSA Survivors Network, the global leader in the fight against MRSA, healthcare-acquired infections and antimicrobial resistance. The 2012 global theme for World MRSA Day, October 2 and World MRSA Awareness Month, October is 'The MRSA Epidemic - A Call to Action'. (Logo:...

2012-07-17 02:27:55

SAN FRANCISCO, July 17, 2012 /PRNewswire/ -- Keiretsu Forum's members recently made a significant investment of more than $3 million to take lead on a Series B fundraising round for Savara Pharmaceuticals. Keiretsu Forum is the world's largest private equity angel investment network. Savara is an emerging specialty pharmaceutical company developing innovative pulmonary drugs for the treatment of serious and life-threatening conditions. "The opportunity to invest in...

2012-07-13 23:03:42

A new law signed into effect by President Obama this week is expected to assist researchers in developing new antibiotics for the most difficult to treat bacteria infections. Called the GAIN Act (Generating Antibiotics Incentives Now), the law provides incentives for companies to develop completely new antibiotics that can treat the most challenging bacterial infections that have become resistant to current treatments. Radnor, PA-based PolyMedix is one company that hopes to benefit from the...

2012-07-09 06:28:23

BALTIMORE, July 9, 2012 /PRNewswire/ -- BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), today announced it received FDA clearance to market the BD MAX(TM) MRSA molecular test in the United States. The assay is performed on the fully-automated BD MAX(TM) System and is designed to rapidly and accurately identify patients colonized with methicillin-resistant Staphylococcus aureus (MRSA). Rapidly and accurately identifying patients enables infection control measures...

2012-07-05 06:33:24

(Ivanhoe Newswire) — An analysis of more than 9 million Department of Defense non-active and active duty personnel revealed that the rates of both community-onset and hospital-onset methicillin-resistant Staphylococcus aureus (MRSA) bacteremia decreased from 2005 to 2010, while the proportion of community-onset skin and soft tissue infections from MRSA has more recently declined. The background information in the article states that the magnitude of invasive MRSA infections as well...

2012-07-04 23:02:49

In analysis that included more than 9 million Department of Defense nonactive and active duty personnel, the rates of both community-onset and hospital-onset methicillin-resistant Staphylococcus aureus (MRSA) bacteremia decreased from 2005 to 2010, while the proportion of community-onset skin and soft tissue infections due to MRSA has more recently declined, according to a study in the July 4 issue of JAMA. "The magnitude of invasive MRSA infections as well as the emergence of...

2012-07-02 21:51:40

Findings highlight importance of appropriate antibiotic use in community settings A new study published in Clinical Infectious Diseases and available online shows how seasonal changes in outpatient antibiotic use — retail sales of antibiotics typically get a boost during the winter — can significantly alter seasonal patterns of drug resistance. The findings suggest that hospital campaigns to reduce inappropriate antibiotic use should be coordinated with efforts in the broader...

2012-06-21 20:47:37

A coating of selenium nanoparticles significantly reduces the growth of Staphylococcus aureus on polycarbonate, a material common in implanted devices such as catheters and endotracheal tubes, engineers at Brown University report in a new study. Selenium is an inexpensive element that naturally belongs in the body. It is also known to combat bacteria. Still, it had not been tried as an antibiotic coating on a medical device material. In a new study, Brown University engineers report that...


Latest Staphylococcaceae Reference Libraries

0_565be8ac4669df235cfa9eb09fa14a3d
2011-04-26 20:59:00

Staphylococcus epidermidis is one of thirty-three known species belonging to the genus Staphylococcus. It is part of our skin flora and can also be found in the mucous membranes and in animals. It is the most common species found in laboratory test due to contamination. It is not usually pathogenic; however, patients with a compromised immune system often risk infection. Infections can be both nosocomial and community acquired and are more of a threat to hospital patients. Hospitals carry...

72_eee8f4e550996ac6ae01af15eddb314c
2011-04-26 20:20:41

Staphylococcus aureus is a facultative anaerobic gram-positive coccus, and is the most common cause of staph infections. It is commonly part of the skin flora found in the nose and on skin. Around 20% of the human population is long-term carriers. It gets its golden color due to its carotenoid pigment staphyloxanthin. The pigment acts as a virulence factor with an antioxidant action that allows the microbe to evade death by reactive oxygen species used by the host immune system. Staphylococci...

More Articles (2 articles) »